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This study aimed at identifying the functions of Cyclin Y using Drosophila 
melanogaster as a model organism. Cyclins are a family of conserved proteins. In 
human, there are 15 known Cyclins from Cyclin A to Cyclin Y (Gopinathan et al., 
2011). Cyclins function in regulation of Cyclin dependent kinase (Cdk) activity 
(Gopinathan et al., 2011; Lim and Kaldis, 2013).  The Cyclin box allows cyclins to bind 
to Cdks. There are more than 20 known Cdks (Gopinathan et al., 2011; Lim and 
Kaldis, 2013). While cyclins are known for their essential roles in regulating the cell 
cycle (e.g. Cyclin A, B, D and E) (Morgan, 1997; Murray, 2004), some cyclins function 
outside of cell cycle regulation. For example, Cyclins C, H and K play roles in 
transcriptional regulation (Akoulitchev et al., 2000; Gopinathan et al., 2011; Lim and 
Kaldis, 2013). There are also several highly conserved cyclins with unknown functions 
such as Cyclin Y. Cyclin Y is the second most highly conserved member of the cyclin 
protein superfamily in metazoans after Cyclin C (Liu and Finley Jr, 2010), which 
suggests an important conserved cellular function. Yet Cyclin Y’s function remains 
poorly characterized. Our lab has previously shown in Drosophila that a Cyclin Y null 
mutant is lethal (Liu and Finley Jr, 2010). Cell culture studies suggest that Cyclin Y, 
localized to the cell membrane by myristoylation, is required for phosphorylation and 
activation of the Wingless (Wg) receptor (Davidson et al., 2009). To study the Cyclin Y 
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functions in vivo, I performed a tissue wide screen in Drosophila melanogaster by 
targeting CycY with a short hairpin RNA (shRNA) in 31 different tissues using the 
Gal4/UAS binary system. The screen suggested that expression of the CycY shRNA 
in specific tissue patterns, including the nervous system and the gut, caused larval 
lethality and other developmental defects. In addition, other phenotypes were 
discovered in the screen in adult flies. Interestingly, expression of the CycY shRNA in 
imaginal discs resulted in bent legs and blistered wings. This is an unexpected 
phenotype if Cyclin Y functions exclusively in the canonical wingless pathway. 
Expression of a myristoylation defective, non-membrane localized Cyclin Y from a 
transgene could partially suppress the shRNA-generated wing blister phenotype, and 
fully rescue a CycY deletion mutant, which also supports a Cyclin Y function outside 
the canonical wingless pathway. Bent legs and blistered wings were previously seen 
in mutants of genes in the cell adhesion and focal adhesion pathways (Brown, 1993; 
Brown, 2000; Brown et al., 2000; Chen et al., 2005). The Rho pathway is one of the 
main pathways that control focal adhesion (Huveneers and Danen, 2009). I tested for 
genetic interactions between Cyclin Y and members of the Rho pathway. 
Overexpression of a positive regulator of the Rho pathway, LIMK1, suppressed the 
wing blister caused by the CycY shRNA. This suggests that Cyclin Y has a 




1.2. Cyclin Y 
Drosophila Cyclin Y was first identified in a yeast two-hybrid screen by Stanyon 
and colleagues (Stanyon et al., 2004). That study focused on the protein interaction 
map of cell cycle regulators. One of the baits in the screen was Eip63E, also known as 
Cdk14. One of the Eip63E interactors identified was CG14939, which was later 
renamed Cyclin Y due to its sequence similarity with human Cyclin Y (CCNY) (Liu and 
Finley Jr, 2010). Drosophila CycY encodes a protein with 406 amino acid residues. 
The Cyclin box is located between regions 205 and 328.  Cyclin Y is the second most 
highly conserved cyclin in metazoans after Cyclin C. This high evolutionary 
conservation suggests essential functions (Liu and Finley Jr, 2010).   
Our lab set out to determine the functions of Cyclin Y using the Drosophila 
model organism (Liu and Finley Jr, 2010). Previous studies in our lab showed that 
homozygous deletion of CycY in Drosophila results in delayed larval growth and pupal 
lethality (Liu and Finley Jr, 2010). Lethality could be rescued by a genomic CycY 
transgene (Liu and Finley Jr, 2010). When maternal CycY is also deleted, 99.6% of 
the CycY null embryos fail to hatch, which demonstrates a requirement for CycY in 
embryogenesis (Liu and Finley Jr, 2010). It also suggests that the reason homozygous 
CycY null flies could develop through puparation is due to the perdurance of maternal 
Cyclin Y and/or downstream products till these stages. Although the CycY null lethality 
emphasizes the essential function of Cyclin Y in development, it masks the chance to 
detect phenotypes that might serve as clues to the specific pathways that require 
Cyclin Y. The tissue wide screen for Cyclin Y that I carried out in this study was 
designed to overcome this issue by targeting Cyclin Y in specific tissue patterns.  
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1.2.1 Cyclin Y’s Cdk partners:  
Several lines of evidence suggest that in Drosophila, Cdk14 is a putative cdk 
partner for Cyclin Y (Liu and Finley Jr, 2010; Stanyon et al., 2004). First, a yeast two-
hybrid screen showed that Drosophila Cdk14 binds to Drosophila Cyclin Y (Stanyon et 
al., 2004). Second, the specificity of the Cyclin Y-Cdk14 interaction was further tested 
through yeast two-hybrid and co-affinity purification (Co-AP) in Drosophila cultured 
cells (Liu and Finley Jr, 2010). Third, Cdk14 loss of function phenocopies the Cyclin Y 
null (Liu and Finley Jr, 2010). Fourth, either knockdown of Cdk14 or Cyclin Y leads to 
a decreased LRP6 (Arrow) phosphorylation in Drosophila S2R+ cells at Sp1490 
(Davidson et al., 2009). Fifth, in Human, CDK14 (PFTK1) and CDK16 (PCTAIRE1) are 
putative Cyclin Y (CCNY) partners as demonstrated through yeast two-hybrid and co-
AP (Jiang et al., 2009; Mikolcevic et al., 2012). Drosophila has no Cdk16 (Liu et al., 
2010). As for C. elegans, PCT-1, a Cdk16 orthologue, was shown to bind to Cyclin Y 
(CYY-1) through a pull-down experiment (Ou et al., 2010). An in vitro kinase assay 
shows that the PCT-1 kinase activity is dependent on the concentration of the CYY-1. 
As the Cyclin Y concentration increases, PCT-1 kinase activity increases (Ou et al., 
2010). Cdk5 is also proposed as a potential Cyclin Y cdk partner.  An in vitro kinase 
assay, shows that the Cyclin Y concentration affects the Cdk5 kinase activity (Ou et 
al., 2010). As the Cyclin Y concentration increases, the Cdk5 kinase activity increases 





1.2.2. Cyclin Y and the canonical Wingless pathway:  
Cyclin Y has been linked to the canonical Wingless pathway (Davidson et al., 
2009). In Drosophila S2R+ cells, Davidson and colleagues (Davidson et al., 2009) 
show that knockdown of Cyclin Y and/or its cdk partner, Cdk14 results in decreased 
phosphorylation of the Wg co-receptor, Arrow at S1490. Knockdown of Cdk14 or CycY 
in S2R+ cells expressing constitutively active human Wg co-receptor, LRP6, 
decreases Wingless signaling when measured by a Wnt activity reporter assay 
(TOPFLASH assay). In Xenopus embryos, knockdown of Cyclin Y in addition to the 
Cyclin Y like-1 gene using morpholinos results in decreased LRP6 phosphorylation at 
S1490 and decreased Wnt signaling as tested with the TOPFLASH reporter assay. 
This decrease in LRP6 phosphorylation could be rescued by injection of human CCNY 
mRNA. In addition, Xenopus embryos treated with CycY morpholinos are anteriorized, 
which is a characteristic phenotype of reduced Wnt signaling as well as LRP6 
knockdown. In human embryonic kidney cells, Davidson and colleagues (Davidson et 
al., 2009) show a protein-protein interaction between LRP6 and Cyclin Y using co-AP. 
This interaction is compromised when the wild type Cyclin Y is replaced by a non-
membrane localized, myristoylation defective G2A Cyclin Y. The G2A Cyclin Y also 
results in a decreased S1490 phosphorylation of LRP6 compared to the wild type 
Cyclin Y. In nocodazole synchronized HEK293T cells, both CCNY and PFTK1 
expression is enriched in the G2/M phase when LRP6 phosphorylation at S1490 is 
also enriched (Davidson et al., 2009). Put together, Davidson and colleagues 
(Davidson et al., 2009) conclude that Cyclin Y is required for membrane recruitment 
and activation of Cdk14, which in turn phosphorylates and activates LRP6 (Arrow). 
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LRP6 activation results in priming and activation of the canonical Wnt signaling 
pathway (Davidson et al., 2009). A role for Cyclin Y in the Drosophila Wg pathway in 
vivo has not been tested. In addition, in Drosophila, defects in the Wingless pathway 
are associated with known phenotypes such as the loss of one or both wings 
(Bejsovec, 2006; Sharma and Chopra, 1976). Yet CycY null escapers and pharates do 
not phenocopy Wingless pathway mutants; e.g., they show no wing loss (Liu and 
Finley Jr, 2010). These findings led us to question whether Cyclin Y functions in the 
canonical wingless pathway or other pathways in vivo in Drosophila (Liu et al., 2010). 
In this study I addressed this question by knocking down arrow in some of the same 
tissue patterns that give CycY specific knockdown phenotypes and comparing the two 
sets of phenotypes.   
 
1.2.3. Cyclin Y and myristoylation: 
In human cell lines, Cyclin Y is tethered to the cell membrane through N-
terminal myristoylation (Davidson et al., 2009; Jiang et al., 2009). The myristoylation 
signal sequence is required for the binding of Cyclin Y and Cdk14 to LRP6 in 
HEK293T cells and for maximal LRP6 phosphorylation at S1490 [7]. The 
myristoylation signal is conserved in Drosophila Cyclin Y (Liu and Finley Jr, 2010), 
which strongly suggests a cell membrane localization of Cyclin Y in Drosophila as 
well. Our lab has previously developed an N-terminally Myc-tagged Cyclin Y that was 
shown to localize mainly in the cytoplasm (Liu, 2010). This is probably because the N-
terminal Myc-tag disrupts Cyclin Y myristoylation (Liu, 2010). Interestingly, Myc-Cyclin 
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Y successfully rescues CycY null lethality (Liu and Finley Jr, 2010). This led us to 
question the importance of Cyclin Y membrane localization for its functions and 
supported our hypothesis that maybe Cyclin Y has functions outside the canonical 
Wingless pathway (Liu et al., 2010).  In this study I developed C-terminally HA or YFP-
tagged Cyclin Y transgenes to study the Cyclin Y subcellular localization in Drosophila 
and I confirmed its putative conserved cell membrane localization. I also developed a 
myristoylation defective C-terminally YFP-tagged CycY transgene. This was used to 
detect whether the membrane localization of Cyclin Y is essential for its function by 
testing whether the myristoylation defective Cyclin Y could rescue the CycY null or 
RNAi phenotypes as efficiently as the wild type Cyclin Y.  
 
1.2.4. Cyclin Y in C. elegans.  
In C. elegans, a CYY-1 null shows mislocalization of the presynaptic 
components (RAB3, SYD-2, SNB-1 and SNG-1) to the dendrites of some motor 
neurons. Notably, CYY-1 null animals also have smaller brood sizes (Ou et al., 2010). 
Double mutants with p35 or Cdk5 result in a significant increase in this mislocalization 
as well as paralyzed worms, which strongly suggests that Cyclin Y and Cdk16 act in a 
parallel pathway to p35 and Cdk5. This study also shows that Cyclin Y binds to and 
activates Cdk16 to help localize the presynaptic components.  While the presence of 
Cyclin Y is essential for the Cdk16 function, the opposite is not true. Overexpression 
of Cyclin Y could significantly rescue the mislocalization defect produced by the Cdk16 
knockout. This indicates that Cyclin Y also acts in a mechanism that does not require 
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Cdk16 to localize the presynaptic components. Since Cdk5 and Cdk16 are closely 
related, Ou and colleagues (Ou et al., 2010) hypothesize that Cdk5 could be the other 
Cyclin Y partner for this function. Indeed, a functional Cdk5 transgene could only 
marginally rescue the Cyclin Y mutants, indicating that Cyclin Y is required for some 
aspects of the Cdk5 function. Also overexpression of the same Cyclin Y that could 
rescue the Cdk16 mutant could not rescue the Cdk16-Cdk5 or Cdk16-p35 double 
mutant. This indicates that the presence of both p35 and Cdk5 together is essential for 
the Cdk16 independent Cyclin Y function in presynaptic component localization (Ou et 
al., 2010).  Finally they show that Cdk5 kinase activity increases in the presence of 
CYY-1 in an in vitro kinase assay (Ou et al., 2010). Further investigation reveals that 
CYY-1 and/or Cdk5 mutants shows significantly increased retrograde transport. Loss 
of function of either the dynein complex components, DHC-1 or NUD-2 rescues the 
presynaptic component mislocalization due to PCT-1 or Cdk5 loss of function. This 
suggested that PCT-1 and Cdk5 are upstream to DHC-1 or NUD-2 and that PCT-1 
and Cdk5 might function in the inhibition of the cytoplasmic dynein complex. CYY-1 
nulls also show accumulation of presynaptic vesicles in specific motor neurons, which 
suggests a role for Cyclin Y in synapse elimination and synaptic remodeling (Park et 
al., 2011). Consistently, the Drosophila CycY mRNA is most highly expressed in the 
nervous system (Chintapalli et al., 2007). This raises the possibility that perhaps one 





1.2.5. Cyclin Y in human disease.  
The human Cyclin Y gene (CCNY) is linked to several disease states. Genome 
wide association studies reveal a SNP in CCNY that is associated with two 
inflammatory bowel disease subphenotypes, Crohn’s disease and ulcerative colitis 
(Franke et al., 2008; Waterman et al., 2011).  Cyclin Y is also upregulated in 
metastatic colorectal cancer cells (Ying-Tao et al., 2005). Cyclin Y was also found to 
be upregulated in two other cancer types, non-small-cell lung cancer (Yue et al., 2011) 
and glioma (Xu et al., 2010). More importantly, Cyclin Y’s expression level impacts the 
growth rate of the tumor cells in xenografts. Cyclin Y knockdown leads to decreased 
cell proliferation and smaller tumor sizes compared to the no knockdown populations 
(Xu et al., 2010; Yue et al., 2011). 
 
1.2.6. Cyclin Y degradation through ubiquitination: 
In HEK293T cells, human Cyclin Y is shown to be autoregulated by the Cyclin 
Y/Cdk14 complex (Li et al., 2014). Binding and activation of Cyclin Y to Cdk14 further 
results in its phosphorylation at serine 71 and serine 73. This results in the formation 
of a phosphor-degron, which allows recognition by the SCF ubiquitin ligase complex 
and Cyclin Y degradation through the ubiquitin proteasome pathway. This degradation 
is dependent on the presence of Cdk14 and its kinase activity since knockdown of 
Cdk14 results in Cyclin Y stability. Overexpression of a kinase defective Cdk14D256A 
also shows decreased Cyclin Y ubiquitin degradation compared to the overexpression 
of a wild type Cdk14 (Li et al., 2014).  
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1.3. Project outline: 
 
In this project, I studied the functions of Cyclin Y using Drosophila as a model 
organism. Drosophila melanogaster is hundreds of millions of years distant from 
human in the phylogenetic tree. At the same time, the Drosophila Cyclin Y protein has 
a 52% sequence identity with human Cyclin Y (Liu and Finley Jr, 2010). The high 
conservation of the protein between species strongly suggests an essential conserved 
biological function for Cyclin Y. It also suggests that Drosophila melanogaster is a 
suitable model organism for this study of the conserved biological functions of Cyclin 
Y. In addition, Drosophila is a well-established model organism that provides a 
powerful in vivo system with a very short life cycle, where an array of state-of-the-art 
genetic and molecular techniques can be easily applied.  
In this study, I used in-vivo phenotypic analysis and localization studies to study 
the Drosophila Cyclin Y functions. I addressed the following specific aims.  
Aim 1: To test the hypothesis that Cyclin Y is involved in molecular pathways outside 
of or in addition to phosphorylation and activation of Arrow in the canonical wingless 
pathway in Drosophila. 
 1.a. To identify specific biological systems and putative molecular pathways that 
require Cyclin Y by screening for tissue-specific Cyclin Y loss of function phenotypes 
using RNAi-mediated knockdown of Cyclin Y in specific tissues. To accomplish this I 
expressed a CycY short hairpin RNA (shRNA) (Ni et al., 2011) in specific tissues by 
using the Gal4/UAS system (Brand and Perrimon, 1993). I screened for lethality in 
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embryos, larvae, pupae and adults. I also characterized other abnormal phenotypes. 
1.b: To determine biological systems where Cyclin Y functions outside the canonical 
wingless pathway. To accomplish this, I knocked down arrow using a dsRNA in the 
same tissue patterns that resulted in abnormal phenotypes in the CycY knockdown 
screen and compared the phenotypes (Ni et al., 2008). 
Aim 2: To test the hypothesis that Cyclin Y does not require membrane localization for 
some of its functions by mutating the myristoylation sequence at the N-terminus of 
Cyclin Y and testing whether the myristoylation defective mutant can complement 
CycY knockdown phenotypes. Cyclin Y and the myristoylation-defective Cyclin Y were 







A TISSUE-WIDE RNAi SCREEN TO IDENTIFY BIOLOGICAL PROCESSES AND 
MOLECULAR PATHWAYS THAT REQUIRE CYCLIN Y 
 
2.1. INTRODUCTION 
Previous studies in our lab showed that homozygous deletion of CycY in 
Drosophila resulted in delayed growth and lethality mostly by the pupal stage (Liu and 
Finley Jr, 2010). This emphasizes the essential function of Cyclin Y in development 
and survival. But the early stage lethality of the CycY null Drosophila masks the 
chance to detect many phenotypes in adult flies that might serve as clues to the 
specific biological functions and molecular pathways that are defective in the absence 
of Cyclin Y such as phenotypes in the wings, eyes as well as any detectable 
behavioral defects. To discover Cyclin Y phenotypes, I carried out a tissue-wide, 
tissue-specific knockdown screen for CycY. In the screen I used RNA interference 
(RNAi) and the Gal4/UAS binary method developed by Brand and Perrimon for 
targeted gene expression in Drosophila (Brand and Perrimon, 1993). Gal4 is a 
transcription regulator in Saccharomyces cerevisiae where it binds to an upstream 
activating sequence (UAS) of several genes (e.g. GAL1 and GAL10) to regulate them 
(Laughon et al., 1984; Laughon and Gesteland, 1984). In the Gal4/UAS system, the 
Gal4 is expressed in Drosophila by using a specific promoter. This promoter can be 
specific to a certain tissue or stage. For example, the elav promoter is specific to the 
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nervous system (Green, 2010) and can be used to express Gal4 in the nervous 
system. A gene of interest, such as a double stranded RNA (dsRNA) or short hairpin 
RNA (shRNA), can be expressed in the same pattern by linking it to a UAS.  
In this screen, by crossing individual fly strains that each express Gal4 under 
the influence of a different tissue-specific gene promoter (“Gal4 driver lines”), with flies 
that have UAS-shRNA for CycY, progeny with both Gal4 and the UAS were obtained. 
These progeny should experience tissue-specific knockdown of CycY by RNA 
interference.  I used 31 different Gal4 lines. I monitored and quantified lethality in each 
of the four stages of Drosophila development (embryos, larvae, pupae and adults).  
For the same reasons I mentioned above, Dongemi Liu (Liu, 2010) developed a 
dsRNA against CycY and tested for knockdown phenotypes using the UAS/Gal4 
system. She showed that expression of the dsRNA ubiquitously with Act-Gal4 resulted 
in lethality at developmental times similar to the zygotic CycY null (Liu, 2010). 
Expression of the dsRNA in posterior wing discs with the en-Gal4 driver resulted in 
decreased posterior wing area, possibly due to reduced cell proliferation, and this 
phenotype could be suppressed by expression of a CycY transgene. Expression of the 
dsRNA in the 69B-Gal4 pattern resulted in extra wing vein formation (Liu, 2010). In 
this study, I made a couple of modifications to the previous one. First, I used a short 
hairpin RNA (shRNA) against CycY that was developed by the pTRiP project (Ni et al., 
2011). This was the lately developed RNAi system at the time when I started this 
study. I used the shRNA because the pTRiP shRNA targets only 21 bp, which are 
designed to be highly specific to the target gene (Ni et al., 2011). This decreases the 
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possibility of off-target gene knockdown (Ni et al., 2011), which is higher with dsRNA 
that are designed to target hundreds of bp of a gene. Second, I expanded the tissue 
specific CycY knockdown study to increase its spatial and temporal details. This was 
achieved by increasing the number and variety of specific tissues being targeted using 
31 Gal4 lines (Appendix A) and also by carefully tracking lethality in each stage of 
development in each of the 31 Gal4 lines as they transitioned from embryos to larvae 
to pupae to adult flies. The detailed analysis increased our chances to detect tissues 
that require Cyclin Y for survival. It also increased our chance to detect phenotypes 
that could guide us to putative biological functions and molecular pathways that 
require Cyclin Y. In this chapter, I discuss the detailed setup of the tissue-wide, tissue-





2.2. MATERIALS AND METHODS  
2.2.1. Fly stocks 
All fly stocks were maintained in vials containing standard cornmeal molasses 
medium and raised at 25°C unless otherwise stated. A fly line (y1 sc* v1; 
p(TRiP.HMS00974) attP2)) from the Harvard Transgenic RNA Interference Project 
(TRiP) expressing a CycY shRNA from a UAS  (Ni et al., 2011) was obtained from the 
Bloomington stock center (BDSC# 34009, Finley lab stock # 918). TRiP.HMS00974 is 
based on the VALIUM20 vector and contains a 21bp shRNA targeting CycY (Hairpin 
ID: SH01655.N) Top Oligo: TGCGATCATCACGCTA GTCTA, Bottom Oligo: TAGACT 
AGCGTGATGATCGCA (Ni et al., 2011). An shRNA against mCherry was used as a 
control. This control fly line (y1 sc* v1; P(VALIUM20-mCherry)attP2) was obtained 
from the same Valium 20 collection (BDSC# 35785, Finley lab stock # 1016) and has 
the same insertion site and genetic background as that of the CycY shRNA line. The 
Gal4 lines used in this study and their expression patterns are listed in appendix A. To 
verify the Gal-4 lines used in this study I crossed each with a line containing UAS 
driving a green fluorescent protein (GFP) (sp/Cyo; UAS-GFP/UAS-GFP) (Source: 
Bloomington Stock # 1521, Finley lab stock # 443) and tested for GFP expression in 
all F1 larvae. L3 larvae of F1 were collected and dissected in PBS under a fluorescent 







2.2.2. Tissue-wide, tissue specific screen for Cyclin Y in vivo: 
2.2.2.1.  Screening Scheme:  
 
Figure 2-1: A scheme of the approach of the tissue-wide CycY knockdown 
screen.   
 
2.2.2.2. Tissue-wide CycY knockdown screen: 
 The tissue-wide knockdown screen was accomplished by using RNA 
interference (RNAi) and the Gal4/UAS binary method, developed by Brand and 
Perrimon for targeted gene expression in Drosophila (Brand and Perrimon, 1993). 
Age matched 1-10 day old virgin female y1 sc* v1; +/+; UAS-shRNA attP2 expressing 
shRNA targeting CycY or mCherry were mated with Gal4 driver lines with 
homozygous Gal4 on chromosome 1 (xx-Gal4; +/+; +/+), 2 (xx-Gal4; +/+), or 3 (+/+; 
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xx-Gal4), where xx is the particular Gal4 driver (Appendix A). In the case of Gal4 
chromosomes that are homozygous lethal (Appendix A), the shRNA lines were mated 
with xx-Gal4/Act-GFP, Cyo or +/+; xx-Gal4/Act-GFP, TM3, Ser, and non-GFP F1 were 
scored. For each tissue-specific knockdown, I quantified the fraction of embryos, 
larvae and pupae that progressed to the next stage. I also quantified survival and the 
presence of any gross abnormalities in adults; specifically, I looked for obvious defects 
in the eye, wing, legs, abdomen & mouth. Images were obtained for gross phenotypes 
using a Leica MZ 16FC stereomicroscope and Spot RT3™ camera. The whole 
experiment was done at 27°C. The screen was performed in independent triplicates, 
where new parent flies were used each time. The test and control crosses were done 
at the same time.  
 To determine lethality, parent flies were allowed to lay eggs in chambers placed 
on apple juice agar plates overnight. After one day, first instar larvae were transferred 
to individual regular fly food vials. After 3 days, the number of unhatched eggs in each 
apple juice agar plate was recorded and the percentage embryonic lethality for the test 
and control groups was calculated from the fraction of laid eggs that remained. 
Embryonic lethality was not monitored for Gal4 lines that were homozygous lethal due 
to the inability to differentiate GFP positive from GFP negative embryos. To calculate 
larval lethality, pupae in the vials, where the first instar larvae were transferred, were 
counted after 6-8 days from the first instar larval transfer. The percentage larval 
lethality for the test and control groups was calculated as the fraction of picked larvae 
that failed to become pupae. Likewise, the percentage pupal lethality for the test and 
control groups was calculated from the fraction of pupae that remained uneclosed 11-
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12 days after the first instar larval transfer. In each case the mean percentage lethality 
and standard error of the mean were calculated from triplicate matings and plotted. 
 
2.2.2.3. Adult survival analysis: 
Eclosed adult males and females (0-1 days old) were transferred to fresh 
regular fly food vials and monitored for longevity for the first 5 days and then once 
every five days until they all died. The flies were transferred to new vials every two 
days for the first 4 days, once on day 5 and then once every five days for the length of 
the experiments. To score the dead flies, for the first 5 days, the flies that were stuck 
to the vials and also not moving were counted as dead. Then every 5 days, the living 
flies were counted and transferred to fresh fly food. For Gal4 lines that are 
homozygous lethal (Appendix A) the Gal4 chromosomes were balanced over Act-
GFP, Cyo or Act-GFP, TM3, Ser and non-GFP L1 larvae were selected for analysis. 
Wilcoxon Rank-Sum test was used to determine the Gal4 expression patterns that 
gave statistically lower median adult survival times in the CycY shRNA groups as 
compared to the mCherry shRNA groups. Gal4 lines with p values <0.05 in each of 
the triplicates were considered CycY shRNA-dependent defective in survival.  
 
2.2.3. Construction of shRNA resistant CycY transgenic flies:  
I expressed shRNA-resistant CycY cDNA using plasmids pTWV-attB and pTWH-attB 





2.2.3.1. Primers and plasmids: 
Primers and plasmids designed and used in this chapter are listed in Appendix B and 
C respectively. 
 
2.2.3.2. Construction of Plasmids pUASt-Gateway-3xHA-attB (pTWH-attB) and 
pUASt-Gateway-Venus-attB (pTWV-attB): 
The plasmids were constructed by first amplifying the Gateway cassette along 
with the Venus (YFP) tag or the 3xHA tag from pTWV (UASt / Gateway vector-Venus / 
C-terminus) and pTWH (UASt / Gateway-3xHA / C-terminus) (Murphy, 2003), 
respectively using Primers NG21 (5’ GAGAACTCTGAATAGGCAATTGGGAAT), and 
NG22 (5’  CCTTCACAAAGATCCTCTAGCTTACGT). The NG21 primer introduced a 
G to C mutation to make an Mfe1 restriction site. Purified PCR products (the Gateway 
casette-Venus or the Gateway casette-3xHA) were digested using Mfe1 and Nhe1 
and inserted into pUASt-attB (Bischof et al., 2007) cut with EcoR1 and Xba1. Inserts 
were verified using PCR. The anticipated plasmid sequences are listed in appendix D 





Figure 2-2. A scheme of the construction plan of the two plasmids pUASt-
Gateway-HA attB (pTWH-attB) and pUASt-Gateway-Venus attB (pTWV-attB) from 
the pUASt-attB vector and the murphy vectors pTWH and pTWV respectively. 
 
2.2.3.3. Construction of the shRNA resistant CycY ORF: 
The shRNA against CycY targets nucleotides 750 to 770 of the CycY ORF. I 
used site directed mutagenesis to introduce two silent point mutations in nucleotides 
759 (C ! A) and 762 (G !C) of the CycY ORF using primers NG15 (5’ 
GCGATCATAACCCTAGTCTACC) and NG16 (5’ GGTAGACTAGGGTTATGA 
TCGC). The CycY ORF was amplified from a CycY cDNA clone obtained from the 
Drosophila Genome Collection series 1 (DGC1) distributed by the Drosophila Genome 
Resource Center (DGRC) (Clone ID: LD31675). In separate PCR reactions, the CycY 




NG16, while the CycY ORF from position 751 to the stop codon was amplified with 
primers NG15 and NG12 (5’ GGGGACCACTTTGTACAAGAAAGCTGGGTCCGAT 
AGTATGGCCACGCTG). NG11 added a Kozak sequence to the 5’ end of the CycY 
ORF as well as the attB1 sequence for Gateway cloning. NG12 removed the stop 
codon, so that Cyclin Y could be tagged at the C-terminus and added the attB2 
sequence to the CycY ORF 3’ end for Gateway cloning. Extension overlap was used 
to fuse the two PCR products. Using the Gateway cloning BP reaction, the ORF was 
inserted into pDonr221 (Invitrogen) to make CycY-2pt-pDonr221 and the inserts were 
sequence verified. The shRNA resistant CycY ORF (CycY-2pt) was transferred into 
the new plasmids, pTWH-attB and pTWV-attB using the Gateway cloning LR reaction. 
The new plasmids containing CycY-2pt-3xHA or CycY-2pt-YFP was inserted into the 
P2 insertion site on chromosome 3 by embryo injection (Genetic Services, Inc.) 
 
2.2.4.  Phenotype specificity experiments (rescue experiments): 
To test whether the phenotypes obtained from the screen result from CycY 
knockdown, I set out to rescue them using shRNA resistant CycY transgenic flies (HA 
and YFP). Fly strains with the Gal4 lines and the shRNA resistant CycY ORF were 
constructed (genotype: xx-Gal4; CycY-2pt-HA or xx-Gal4; CycY-2pt-YFP). These flies 
were crossed with the y1 sc* v1; +/+; UAS-shRNA attP2 flies for CycY or for mCherry 





2.2.5. Single wing analysis: 
Single wings were dissected from adult female flies, mounted with light mineral 
oil on glass slides and made flat with the coverslips and imaged. The wings were 
examined using the Leica MZ 16FC stereomicroscope. Images of the single wings 
were taken using the Spot RT3™ camera. In the case of engrailed driven posterior 
wing blisters, Image J software was used to measure the area of the wing blisters as 













2.3.1. Expression of a CycY shRNA in specific tissue patterns causes larval 
lethality and other developmental defects 
Previous studies showed that CycY null flies arrest before reaching the adult stage 
and that CycY expression is required throughout development (Liu and Finley Jr, 
2010). To identify tissue-specific requirements for Cyclin Y, I used the Gal4/UAS 
system and RNAi to knock down expression of CycY in a wide range of tissues. I 
expressed an shRNA targeting CycY (Ni et al., 2011) in 31 different Gal4 expression 
patterns, including the nervous system, muscle, gut, circulating cells, imaginal discs, 
and others. The Gal4 expression patterns were verified by examining UAS-GFP 
expression in L3 larvae (Appendix A).  
For each Gal4 line I scored lethality at each developmental stage for the shRNA-
expressing strain relative to age-matched controls expressing an shRNA for mCherry 
(Methods). As expected from the lethality of a CycY null (Liu and Finley Jr, 2010), 
ubiquitous expression of the CycY shRNA using Act5C-Gal4 was lethal, where 100% 
of the flies died by the larval stage (Figure 2-4). In contrast, expression of the shRNA 
in most of the specific tissue patterns resulted in no significant lethality or overt 
phenotypes, suggesting that Cyclin Y may be required only in specific tissues for 
survival or development. Expression of the CycY shRNA in seven specific patterns led 
to significant early stage lethality (Table 2-1). For most of these, lethality occurred in 
the larval stage. Expression of the shRNA in three of these patterns (24B-Gal4, ptc-
Gal4, and 69B-Gal4) led to nearly complete larval lethality, while two of these patterns 
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(ptc-Gal4 and 69B-Gal4) also led to significant embryonic lethality. Like Act-5C-Gal4, 
24B-Gal4 driven CycY knockdown resulted in death at the first instar larval stage. All 
first instar larvae showed body rigidity and immobility before dying. Most of them were 
bent in the head region. 24B-Gal4 drives expression in the mesoderm, larval muscles, 
nervous system, and trachea (Osterwalder et al., 2004; Staehling-Hampton et al., 
1994; Suster et al., 2003) (Appendix A). Both ptc-Gal4 and 69B-Gal4 patterns include 
expression in the nervous system, the gut, salivary glands and imaginal discs 
(Appendix A) (Brand, 1997; Gettings et al., 2010; Monastirioti, 2003; Page, 2002). 
69B-Gal4 is also expressed in patches of the epidermis (Staehling-Hampton et al., 
1994) (Appendix A). Two patterns (en-Gal4 and c601-Gal4) led to 35-60% larval 
lethality, and a significant fraction of the survivors arrested as pupae. En-Gal4 and 
c601-Gal4 drive expression in the gut. En-Gal4 also drives expression in the posterior 
wing discs and some parts of the nervous system. C601-Gal4 also drives expression 
in the salivary glands (Gettings et al., 2010; Harrison et al., 1995; Johnson et al., 
1995; Sozen et al., 1997) (Appendix A). Mild but statistically significant larval lethality 
was seen with cg-Gal4 and pnr-Gal4 driven CycY shRNA. Cg-Gal4 drives expression 
in hemocytes, fat body and lymph glands (Hennig et al., 2006) (Appendix A). Pnr-Gal4 
drives expression in denticle belts, salivary glands, and imaginal discs (Calleja et al., 
1996; Giagtzoglou et al., 2005) (Appendix A). Only one expression pattern (ser-Gal4) 
led to significant lethality starting only at the pupal stages. Ser-Gal4 drives expression 
in the nervous system and imaginal discs (Fleming et al., 1997; Hukriede et al., 1997) 
(Figures 2-3, 2-4 and 2-5, Table 2-1 and Appendix A).  
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Expression of the CycY shRNA in some specific patterns led to significant adult 
survival defects (Table 2-1, Figure 2-6 and Appendix F and G). The survival defects 
were observed in both males and females with 48Y-Gal4 but primarily in females with 
D42-Gal4, Aug21-Gal4, and ELAV-Gal4. Expression of the CycY shRNA in the 112A-
Gal4 pattern led to survival defects specifically in males. Elav-Gal4 specifically drives 
expression in the nervous system (Lin and Goodman, 1994; Zhan et al., 2004), while 
48Y-Gal4 expresses in the nervous system, the gut and parts of the epidermis (Table 
2-1) (Martin-Bermudo et al., 1997; Riese et al., 1997; Szuts et al., 1998). 112A-Gal4, 
D42-Gal4 and Aug-21-Gal4 also drive expression in the nervous system plus other 
tissue patterns, including the gut for 112A-Gal4 the salivary glands for D42-Gal4, and 
the corpora allata and larval ring gland for Aug-21-Gal4 (Crowner et al., 2002; Larkin 
et al., 1996; Martin-Bermudo et al., 1997; Nitz et al., 2002; Riese et al., 1997; Szuts et 
al., 1998; Thummel, 2010; Yeh et al., 1995) (Table 2-1). En-Gal4 and Ser-Gal4 were 
only tested in females because almost no male adults emerged. Expression of the 
CycY shRNA in the en-Gal4 expression pattern in the females led to survival defects 






Table 2-1: Summary of the results obtained from the tissue wide CycY 
knockdown screen. 
Gal4 line Lethality  
Survival 
Defects Other abnormal phenotypes 
E L P A 
24B  100% NA NA Immobile 1
st
 instar larvae that die.  
Elav ND   + (♀)  
Cg  7.3%    
Ser   50%  Wing blisters. 
C601 ND 34.7% 8%   
Pnr  14%   Wing blisters. 
48Y    +++       (♂ & ♀) 
Bent legs, locomotion defects,  
unflexed wings and probosces. 
En  61.2%   Wing blisters 
Ptc 84.7% 95.2% NA NA  
69B 64.3% 89.6% NA NA  
Act5c ND 100% NA NA Immobile 1
st
 instar larvae that die. 
112A    + (♂)  
D42    +++ (♀)  
Aug21    + (♀)  
Lethality is the fraction of live animals that failed to progress from the indicated stage 
to the next stage.  
E: Embryonic lethality. L: Larval lethality. P: Pupal lethality. A: Adult survival defects.  
Blanks indicate no significant lethality or survival defects.  
ND = Not done because the Gal4 line is homozygous lethal.  
NA = Not applicable due to high percentage lethality of previous stages.  
Numbers represent mean percentage lethality of independent triplicates.  
+++ p<0.0005; ++ p<0.005; + p<0.05, the highest p-values, in the triplicate survival 




Figure 2-3. Embryonic lethality due to CycY shRNA expression in specific tissue 
patterns.   The percent of laid eggs that hatched from females expressing the CycY 
shRNA or the mCherry shRNA in the Gal4 patterns is indicated.  A significant difference 
between the CycY shRNA and the mCherry shRNA in the ptc-Gal4 and 69B-Gal4 
patterns indicates CycY shRNA-dependent embryonic lethality (*p<0.05). The Gal4 lines 
are arranged in ascending order according to their p-values. The x-axis shows the 
different Gal4 drivers used in the screen and the y-axis shows the % of eggs that fail to 














Figure 2-4. Larval lethality due to CycY shRNA expression in specific tissue 
patterns. Expression of CycY shRNA in 8 Gal4 expression patterns (24B-Gal4, Act5C-
Gal4, Ptc-Gal4, En-Gal4, 69B-Gal44, c601-Gal4, cg-Gal4 and pnr-Gal4) led to 
significant larval lethality (*p<0.05) compared to the mCherry shRNA control. The Gal4 
lines are arranged in ascending order according to their p-values. The x-axis shows the 
different Gal4 drivers used in the screen and the y-axis shows the % of larvae that died. 








Figure 2-5. Pupal lethality due to CycY shRNA expression in specific tissue 
patterns. Expression of the CycY shRNA in the c601-Gal4 and Ser-Gal4 expression 
patterns led to significant pupal lethality compared to the mCherry shRNA control 
(*p<0.05). The Gal4 lines are arranged in ascending order according to their p-values. 
The x-axis shows the different Gal4 drivers used in the screen and the y-axis shows the 






















Figure 2-6: Adult Survival Defects due to CycY shRNA expression in specific 
tissue patterns. Expression of the CycY shRNA in 48Y-Gal4, D42-Gal4, Aug21-Gal4, 
ELAV-Gal4 and 112A-Gal4, led to adult survival defects. The blue line represents the 
CycY shRNA test group and the red line represents the mCherry shRNA control group. 
The x-axis shows the age in days and the y-axis shows the mean percentage living flies 
on this day based on three independent experiments. 
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In summary, expression of an shRNA targeting CycY in several specific tissue 
patterns resulted in larval or pupal lethality or adult survival defects. The Gal4 lines that 
caused significant lethality in more than one stage (such as 69B-Gal4 and ptc-Gal4) 
suggest a requirement for CycY in those expression patterns during more than one 
developmental stage. This is in agreement with previous studies on CycY null flies 
where different regimes of heat shock induced expression of a CycY transgene 
revealed that Cyclin Y is required in embryos, larvae and pupae, as well as in adults for 
survival (Liu and Finley Jr, 2010). A common system being targeted in Gal4 lines that 
caused early stage lethality or adult survival defects is the nervous system, suggesting 
an important role for Cyclin Y in the nervous system.  
 
2.3.2. Other phenotypes that emerged from the tissue-wide screen:  
 
In addition to monitoring stage lethality in the tissue wide screen, I set out to 
identify abnormal phenotypes in the adult flies. The tissue wide CycY knockdown 
screen revealed some abnormal phenotypes in the adult flies. Those phenotypes were 
monitored and quantified as explained in detail in this section. In addition to their 
importance in confirming biological systems that require Cyclin Y, those phenotypes 
were useful guides to putative molecular pathways that require Cyclin Y by matching 






2.3.2.1. Adult flies are underdeveloped and have unflexed limbs upon expression 
of the CycY shRNA in the 48Y-Gal4 pattern.  
 When the CycY shRNA was expressed in the 48Y-Gal4 expression pattern, 
many adults were found unable to move. A closer look at the flies showed that they had 
bent legs, which impeded them from moving (Figure 2-7). Many of those flies appeared 
to have smaller abdomens and unflexed wings and probosces. I found that 83% (+/-9) 
of the 48Y-Gal4 driven CycY shRNA adults had bent legs (Fig. 2-7 B). To test whether 
this phenotype specifically resulted from knock down of CycY expression, I constructed 
an shRNA-resistant CycY-YFP transgene with two point mutations in the shRNA target 
sequence (Methods). Expression of this shRNA-resistant CycY-YFP in the 48Y-Gal4 
pattern along with the CycY shRNA resulted in a ~4-fold reduction in the fraction of 
adults with bent legs (Fig. 2-7 B). This suppression is not due to dilution of Gal4 by the 
additional UAS since a UAS-GFP transgene control only mildly suppressed the bent leg 
phenotype (Fig. 2-7 B). These results strongly suggest that the bent legs phenotype in 








Figure 2-7. Knockdown of CycY in the 48-Y Gal4 expression pattern results in 
underdeveloped flies with bent legs, unflexed wings and mouthparts and small 
abdomens. A.i. 48Y-Gal4>CycY shRNA fly, underdeveloped and with bent legs. A.ii. 
Normal 48Y-Gal4>mCherry shRNA fly. B. Percentage of flies with bent legs (Methods). 
CycY shRNA resulted in 83% (+/-9) of flies with bent legs compared to 0% of flies with the 
mCherry shRNA. The CycY shRNA bent leg phenotype is partially rescued using shRNA-
resistant CycY transgenes, CycY-2pt-YFP, where only 24% (+/-4) show bent legs. This 
suppression is not due to dilution of Gal4 by the additional UAS since a UAS-GFP 
transgene control only mildly suppressed the bent leg phenotype to 65% (+/-1) of the 
flies. The x-axis shows the % of flies with bent legs and the y-axis shows the different 













2.3.2.3. Expression of the CycY shRNA in wing imaginal discs causes wing 
blisters.  
 Expression of the CycY shRNA in the posterior portion of wing discs by en-
Gal4 caused a wing blister phenotype in the posterior portion of wings in 100% of the 
flies (Figure 2-8). This phenotype was not seen with the mCherry shRNA control. 
ShRNA-resistant CycY transgenes expressing HA-tagged or YFP-tagged Cyclin Y in the 
same expression pattern significantly reduced the wing blister phenotype severity (Fig. 
2-8 B). Although 100% of the flies still had blisters, the average area of the posterior 
wing covered by the blister was reduced from 62% to 42% by expression of Cyclin Y-HA 
(p=3.78e-9) and to 34% by expression of Cyclin Y-YFP (p=6.03e-15), but was not 
significantly reduced by the presence of other UAS transgenes (Fig. 2-8 B). A wing 
blister phenotype was also seen when the CycY shRNA was expressed in the distal 
portion of the wing using the ser-Gal4 driver (Fig. 2-9). This phenotype was less 
penetrant than that driven by en-Gal4; 46% of the ser-Gal4 > CycY shRNA flies had 
distal wing blisters, while none of the ser-Gal4 > mCherry shRNA group showed this 
phenotype. The fraction of animals with blisters could be significantly reduced by 
expression of shRNA-resistant transgenes, Cyclin Y-HA or Cyclin Y-YFP, to 10% (+/-4, 
p=3.59e-05) or 3%(+/-2, p=9.01e-07), respectively but not by the presence of additional 
UAS transgenes (Fig. 2-9 B). Combined, these results indicate that specific knockdown 
of CycY in the wing disc causes wing blisters.   
 




Figure 2-8. Expression of the CycY shRNA in the posterior wing discs results in 
wing blister formation and no wing notching. En-Gal4 driven expression of the CycY 
shRNA results in the formation of a blister (A.i) that covers 61.77% (+/- 1.68) of the 
posterior area of the wing (B). The mCherry knockdown control shows normal wings 
(A.ii). (B) The wing blister phenotype can be suppressed with shRNA-resistant CycY 
transgenes: CycY-2pt-HA reduced the blistered area to 42.16% (+/-2.46) (p=3.78e-9), 
while CycY-2pt-YFP reduced the blistered area to 34.34% (+/-2.56) (p=6.03e-15). The 
x-axis shows the % the posterior wing area that is blistered and the y-axis shows the 




Figure 2-9. Expression of the CycY shRNA in the distal wing results in blister 
formation and no notching. Ser-Gal driven expression of the CycY shRNA results in 
the formation of a wing blister, whereas the mCherry shRNA control shows normal 
wings (A.ii). (B) The wing blister phenotype can be suppressed with shRNA resistant 
CycY transgenes. The CycY-2pt-HA or CycY-2pt-YFP reduced the number of flies with 
wing blisters from 46% (+/- 2) with the CycY shRNA alone to 10% (+/- 4, p=3.59e-05) or 
3%(+/-2, p=9.01e-07), respectively. The x-axis shows the % of flies with dorsal wing 
blisters and the y-axis shows the different genotypes tested in this experiment. Error 








2.4. DISCUSSION AND CONCLUSIONS 
 In this chapter, I carried out a tissue-wide, tissue-specific screen using the 
Gal4-UAS binary system to discover biological processes and molecular pathways that 
require CycY. Our screen showed that expression of a CycY shRNA in several tissue 
patterns resulted in lethality in different developmental stages. Lethality occurred in the 
larval stage in the majority of the cases. The nervous system was a common tissue 
pattern between several Gal4 drivers that showed lethality. The Gal4 drivers 69B-Gal4, 
ptc-Gal4, 24B-Gal4, en-Gal4 and ser-Gal4 all express in the nervous system and 
caused larval or pupal lethality when driving expression of the CycY shRNA (Table 2-1 
and Appendix A). Combined with the fact that CycY is expressed at its highest level in 
the larval nervous system relative to other tissues (Murali et al., 2014), these results 
suggest that Cyclin Y has important functions in the Drosophila nervous system. 
Interestingly, however, expression of the CycY shRNA with the pan-neural driver elav-
Gal4 did not result in significant larval or pupal lethality, though it did decrease adult 
viability. This could be explained if elav-Gal4 drives a lower expression level than the 
other Gal4 lines. Those findings are consistent with a role for Cyclin Y in the nervous 
system that is suggested in a Drosophila large-scale elav-Gal4 driven dsRNA 
knockdown study where CycY knockdown using a dsRNA resulted in defects in the 
neuromuscular junctions (Valakh et al., 2012). Cyclin Y was also shown to function in 
the C. elegans nervous system, specifically in synapse elimination and neural circuit 
rewiring (Ou et al., 2010; Park et al., 2011).  
 Expression of the CycY shRNA in the 48Y-Gal4 expression pattern, which 
includes the nervous system, gut, and parts of the epidermis, resulted in 
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underdeveloped flies with small abdomens, bent legs, and unflexed wings and 
probosces. Many of those flies had locomotion defects, most probably due to the bent 
legs. They also had survival defects. While many flies died in the pupal stage, all of the 
adult flies died much earlier than the mCherry knockdown flies (Fig. 2-6 and 2-7). 
Similar phenotypes were observed in CycY null escaper flies, which are 
underdeveloped and show bent legs and hence locomotion defects. About 50% of 
escapers have unflexed wings (n=6) (Liu and Finley 2010 and data not shown). This 
supports the conclusion that the phenotypes induced by 48Y-Gal4 driven expression of 
the CycY shRNA are Cyclin Y specific.  
 The screen also indicated that expression of a CycY shRNA in wing discs 
results in wing blisters (Fig 2-8 and 2-9). This phenotype occurs due to failure of cell 
adhesion between the two epithelial sheets that form the wing blades and their basal 
membrane. The hemolymph collects between the epithelial layers and forms the wing 
blister. The excess hemolymph is eventually absorbed into the body resulting in a 
crumpled wing appearance (Brown, 1993; Brown, 2000; Brown et al., 2000). Expression 
of the CycY shRNA in wing discs with en-Gal4 and ser-Gal4 resulted in variable levels 
of wing blisters that could be partially suppressed with RNAi-resistant CycY transgenes. 
Wing blistering is an unexpected phenotype if the main role of Cyclin Y is to recruit 
Cdk14 to the cell membrane to activate the Wg co-receptor Arrow, as suggested from 
cell culture studies (Davidson et al., 2009). This finding supports our hypothesis that 







CYCLIN Y SUBCELLULAR LOCALIZATION IN DROSOPHILA 
 
3.1 INTRODUCTION 
 In human cell lines, Cyclin Y is tethered to the cell membrane through 
myristoylation at its N-terminus (Davidson et al., 2009; Jiang et al., 2009). Myristoylation 
is a co-translational or post-translational modification where myristate, a 14-carbon 
saturated fatty acid, is attached to the N-terminal glycine (Maurer-Stroh et al., 2002; 
Wright Mh Fau - Heal et al.). Myristoylation is catalyzed by N-myristoyltransferase 
(NMT) where the N-terminal glycine is essential for this chemical reaction (Maurer-Stroh 
et al., 2002; Wright Mh Fau - Heal et al.). Therefore, a G2A mutation in human Cyclin Y 
results in a myristoylation defective, non-membranous Cyclin Y (Davidson et al., 2009; 
Jiang et al., 2009).  The myristoylation signal sequence is conserved in Drosophila 
Cyclin Y (Liu and Finley Jr, 2010), which led us to expect that Cyclin Y is membrane 
localized in Drosophila as well. In this chapter, using the Cyclin Y-YFP transgene and 
transgenic flies, I showed that Cyclin Y is indeed localized at the cell membrane in 
S2R+ and S2 cells as well as in vivo in wing imaginal discs.  
Our lab has previously developed an N-terminally Myc-tagged Cyclin Y that was 
shown to localize mainly in the cytoplasm (Liu, 2010). The cytoplasmic localization of 
Myc-Cyclin Y is probably due to disruption of the myristoylation sequence by the N-
terminal Myc-tag. Interestingly, Myc-Cyclin Y partially rescues CycY null lethality (Liu 
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and Finley Jr, 2010). This suggests that some of the Cyclin Y functions do not require 
the Cyclin Y membrane localization (Liu, 2010).  
In this chapter, I investigated the requirement of Cyclin Y membrane localization 
for Cyclin Y functions, specifically in the cell adhesion function in the wing discs. This 
was accomplished by testing the ability of shRNA resistant YFP-tagged Cyclin Y, that 
either contain or lack the myristoylation signal, to complement CycY mutants or 
suppress CycY shRNA phenotypes. Consistent with the N-terminally tagged Myc-Cyclin 
Y results, some CycY shRNA phenotypes, such as the wing blisters were suppressed 
by the myristoylation defective Cyclin Y, which supports that membrane localization, is 















3.2.  MATERIALS AND METHODS  
3.2.1. Construction of the shRNA resistant CycY-G2A-2pt-YFP fly strain.  
The CycY-G2A-2pt plasmid was made by PCR amplifying CycY-2pt from CycY-
2pt-pDonr221 (Chapter 2) using primers NG12 and NG17 (5’ 
GGCAAAATGGCCAACAAGAAC), which introduces the G2A mutation. An attB1 was 
added to the 5’ end of the PCR product by amplifying with DM1 (5’ 
GGGGACAAGTTTGTACAAAAAAGCAGGCT) and NG12 and the product was inserted 
into pDonr221 using a Gateway BP reaction to construct CycY-G2A-2pt-pDonr221, 
which was sequence verified. CycY-G2A-2pt was transferred into pTWV-attB using the 
Gateway LR reaction. The new plasmid was inserted into the P2 insertion site on 
chromosome 3 by embryo injection (Genetic Services, Inc.) 
 
3.2.2. Rescue experiments using the myristoylation defective transgenic flies. 
To test the importance of the membrane localization through myristoylation on the 
Cyclin Y functions, I set to rescue those phenotypes using the G2A shRNA resistant 
CycY transgenic flies (YFP) and compare the results to those obtained from the shRNA 
resistant CycY transgenic flies (YFP) used in Chapter 2. As in Chapter 2, fly strains with 
the Gal4 lines and the G2A shRNA resistant CycY ORF were constructed (genotype: 
xx-Gal4; CycY-G2A-2pt-YFP). These flies were crossed with the y1 sc* v1; +/+; UAS-





3.2.3. Immunofluorescence and Immunohistochemistry: 
3.2.3.1. Localization studies in S2R+ and S2 cells: 
S2R+ and S2 cells were transfected according to the protocol described by 
Dongmei Liu (Liu, 2010). Briefly, S2R+ cells and S2 cells were seeded in 6 well plates 
(2 x 10 e6 cells /well and 2ml of Schneider media). The next day, the cells were 
transfected with 10 µl of 50 ng/µl UAS-CycY-2pt or UAS- CycY-G2A-2pt and 10 µl of 50 
ng/µl pMT-Gal4 using the Effectene transfection reagent (30 µl ) (Qiagen). The next day, 
220 µl of 10mM CuSO4 was added to drive induction of the Cyclin Y-YFP in the cells. 
The cells were harvested and plated on slide coverslips that were coated with 
Concanavalin A (Sigma C5275).  The coverslips were stained with 50 µl of DAPI (Sigma) 
(1 µg/mL in PBX (PBS + 0.1% Triton-X 100) + 5% glycerol) then were placed on slides 
with Vectashield mounting media. Images were taken with a Zeiss fluorescent 
microscope.  
 
3.2.5.2. Localization studies in vivo in Drosophila wing discs: 
UAS-2pt-CycY or UAS-G2A-2pt-CycY flies were crossed with apterous-Gal4 flies 
and grown in regular vials at 27°C. Wing discs from wandering third instar larvae were 
dissected in phosphate buffered saline (PBS) (pH- 7.4, 10 mM PO43−, 137 mM NaCl, 
and 2.7 mM KCl). The imaginal discs were fixed in PBS with 4% paraformaldehyde for 
20 minutes at room temperature. Then the wing discs were blocked with 1ml of PBX 
(PBS + 0.1% Triton-X 100) and 5% BSA for 1 hour at room temperature. Following that, 
the wing discs were placed in wells with 50 µl of DAPI (Sigma - 1 µg/mL in PBX + 5% 
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glycerol) for 20 minutes. Then they were washed with PBS and mounted on slides with 


























3.3.1. Cyclin Y is localized to the cell membrane in Drosophila through 
myristoylation.  
To determine the subcellular localization of Cyclin Y in Drosophila cells, I induced 
the expression of wild type and myristoylation defective (G2A) Cyclin Y-YFP in S2R+ 
and S2 cells. S2 and S2R+ cells are derived from late embryos. S2R+ cells are 
adherent cells (Schneider, 1972). S2 cells are semi adherent cells (Yanagawa et al., 
1998). The cells were transfected with pMT-Gal4 and pUASt-CycY-YFP or pUASt-
CycY-G2A YFP. As indicated in Figure 3-1, wild type Cyclin Y was localized to the cell 
membrane in S2R+ cells (3-1.a.) as well as in S2 cells (3-1.b.), while the myristoylation 
defective Cyclin Y G2A-YFP was localized to the cytoplasm and the nucleus (3-1. c. and 
d.). Similar Cyclin Y localization results were obtained in vivo in Drosophila L3 larval 
wing discs (Fig. 3-2) where apterous-Gal4 driven wild type Cyclin Y was localized to the 
cell membrane while the Cyclin Y G2A-YFP was localized to the cytoplasm. These 
results are consistent with the human Cyclin Y localization studies (Davidson et al., 




Figure 3-1. Cyclin Y localizes to the cell membrane in Drosophila cells through a 
myristoylation signal sequence. YFP is membrane localized in Drosophila S2R+ (a.) 
and S2 (b.) cells transfected with UAS-2pt-CycY and pMT-Gal4 and at the cytoplasm 
and the nucleus in Drosophila S2R+ (c.) or S2 (d.) cells transfected with CycY-G2A-2pt-
CycY and pMT-Gal4 (Methods). 




Figure 3-2. Cyclin Y localizes to the cell membrane in vivo in Drosophila L3 wing 
discs through a myristoylation signal sequence. YFP is membrane localized in 
Drosophila third instar larval wing discs ubiquitously expressing CycY-2pt-YFP (ap-
Gal4/+; UAS-CycY-2pt-YFP/+) and at the cytoplasm and the nucleus in wing discs of 
flies expressing a myristoylation defective Cyclin Y, CycY-G2A-2pt YFP (Genotype: ap-
Gal4/+; UAS-CycY-G2A-2pt-YFP/+). 
 
3.3.2. The effect of membrane localization on the Cyclin Y functions.  
In the tissue-wide screen discussed in Chapter 2, I found that expression of the 
CycY shRNA in the engrailed or serrate expression patterns resulted in wing blister 
formation in the posterior wing disc or the distal wing portion respectively.  This 
phenotype is an indication of a cell adhesion defect (Brown, 1993; Brown, 2000; Brown 
et al., 2000). To study the effect of the membrane localization of Cyclin Y on its cell 
adhesion function, I attempted to rescue the wing blister phenotype using the 
myristoylation defective Cyclin Y G2A-YFP and compared the rescue results to those of 
the Cyclin Y-YFP shown in Chapter 2. The myristoylation defective Cyclin Y G2A-YFP 
could suppress the CycY shRNA-induced wing blister phenotype. En-Gal4 expression 
of the shRNA caused 64% (+/-2) of the posterior wing to be blistered, which was 
reduced to 44.5% (+/- 2) by co-expression of Cyclin Y G2A-YFP (Figure 3-3). This is 
significantly less than the UAS-GFP control with the Cyclin Y knockdown where 58.4% 
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(+/- 2.4%) of the wing area was blistered (p=5.0e-5) (Figure 3-3). Also, the 
myristoylation defective Cyclin Y G2A-YFP could suppress the wing blister phenotype 
due to expression of the CycY shRNA in the serrate pattern. Ser-Gal4 expression of the 
CycY shRNA resulted in 46% (+/- 2) of the adults having wing blisters, which was 
reduced to 5% (+/- 4) by co-expression of Cyclin Y G2A-YFP (Figure 3-4). This is 
significantly less than the UAS-GFP control with the Cyclin Y knockdown where 31% 
(+/- 14%) of the flies showed blistered wings (p=0.04) (Figure 3-4). Put together these 
results suggest that membrane localization is not essential for Cyclin Y to suppress the 
wing blister phenotype induced by the CycY shRNA expression.  
 
 
Figure 3-3. Membrane localization is not essential for Cyclin Y to suppress the 
blister phenotype in the posterior wing. A myristoylation defective CycY transgene 
(CycY-G2A-2pt-YFP) significantly reduces the wing blister produced by the Cyclin Y 
shRNA in the posterior wing portion from 64%(+/-2) to 44.5% (+/- 2) defective area. This 
is significantly less than the UAS-GFP control where 58.4% (+/- 2.4) of the wing area 
was blistered (p=5.0E-05). All data other than the CycY-G2A-2pt-YFP is from Fig. 2-8. 
The x-axis shows the % the posterior wing area that is blistered and the y-axis shows 







Figure 3-4. Membrane localization is not essential for Cyclin Y to suppress the 
blister phenotype in the distal portion of the wing. The myristoylation defective 
CycY transgene (CycY-G2A-2pt-YFP) reduces the number of flies with wing blisters 
from 46% (+/-2) to 5% (+/- 4). This is significantly less than the UAS-GFP control where 
31% (+/- 14) of the wing area was blistered (p=0.04). All data other than the CycY-G2A-
2pt-YFP is from Fig. 2-9. The x-axis shows the % of flies with dorsal wing blisters and 
the y-axis shows the different genotypes tested in this experiment. Error bars = S.E.M.  
 
The Cyclin Y-G2A transgene failed to rescue the bent leg phenotype induced by 
the 48Y-Gal4 driven CycY knockdown. As indicated in Figure 3-5, while the Cyclin Y-
YFP could suppress the bent leg phenotype caused by the CycY shRNA reducing the 
flies with bent legs from 83% (+/-9) to 54%(+/-10), the Cyclin Y-G2A mutant was no 
better than the UAS-GFP control at suppressing bent legs (p=0.24). This result 
suggests that the membrane localization might be required for preventing the bent legs. 
An alternate explanation is perhaps the 48Y-Gal4 induced Cyclin Y G2A expression 





Figure 3-5. Cyclin Y membrane localization may be essential for preventing the 
bent leg formation. Unlike Cyclin Y (CycY-2pt-YFP), the myristoylation defective CycY 
transgene (CycY-G2A-2pt-YFP) could not significantly reduce the number of flies with 
bent legs in flies expressing the CycY shRNA (p=0.24). All data other than the CycY-
G2A-2pt-YFP is from Fig 2-4. The x-axis shows the % of flies with bent legs and the y-













3.4. DISCUSSION AND CONCLUSIONS: 
In this Chapter, I studied Cyclin Y localization in Drosophila. I showed that Cyclin 
Y is membrane localized when expressed in S2R+ cells, S2 cells and in vivo in 
Drosophila wing discs. A G2A mutation in Cyclin Y, that disrupts the myristoylation 
signal sequence (Maurer-Stroh et al., 2002; Wright Mh Fau - Heal et al.), resulted in 
mislocalization of Cyclin Y to the cytoplasm and the nucleus. This indicates that in 
Drosophila, the Cyclin Y membrane localization is due to the myristoylation signal 
sequence.  
I then investigated the effect of membrane localization through myristoylation on 
the Cyclin Y functions. I showed that membrane localization was not required for the 
putative roles for Cyclin Y in cell adhesion since the myristoylation defective, non 
membrane localized, Cyclin Y G2A could partially suppress the wing blister phenotype 
induced by CycY shRNA expression in the wing discs.  
 Previous studies have shown that human Cyclin Y is localized at the cell 
membrane through an N-terminal myristoylation (Davidson et al., 2009; Jiang et al., 
2009). This myristoylation signal sequence is required for Cyclin Y to bind to LRP6 in 
HEK293T cells and for maximal LRP6 phosphorylation at Sp1490 in combination with 
Cdk14 (Davidson et al., 2009). Since the myristoylation defective Cyclin Y could rescue 
the CycY shRNA induced wing blister phenotype, these results support the hypothesis 
that Cyclin Y may have some functions outside the canonical Wg pathway in Drosophila 






CYCLIN Y HAS FUNCTIONS OUTSIDE THE CANONICAL WINGLESS PATHWAY 
 
4.1. INTRODUCTION 
Studies in human and Drosophila cultured cells have suggested a possible role 
for Cyclin Y in the canonical Wingless pathway (Davidson et al., 2009). Knockdown of 
Cyclin Y and/or its Cdk partner, Eip63E (Cdk14), in cultured cells results in decreased 
phosphorylation of the Wingless (Wg) or Wnt co-receptor, LRP6 (Arrow in Drosophila) 
and decreased expression of Wg/Wnt reporter genes. Maximal LRP6/Arrow 
phosphorylation and Wg/Wnt reporter activation also requires an N-terminal 
myristoylation signal in Cyclin Y, which facilitates recruitment of Cdk14 to the cell 
membrane (Jiang et al., 2009) where it can phosphorylate and activate Arrow/LRP6 
(Davidson et al., 2009). 
However, the CycY null does not phenocopy loss of function mutations in 
members of the canonical Wg pathway, including arrow (Sharma and Chopra, 1976; 
Wehrli et al., 2000; Willert et al., 1999); e.g., there is no wing loss or wing notching in 
the adult CycY null escapers (Liu and Finley Jr, 2010). In addition, Cyclin Y with an N-
terminal Myc tag, which disrupts the myristoylation sequence, is able to rescue the 
lethality of the CycY null (Liu and Finley Jr, 2010), suggesting that membrane 
localization is not required for at least some of the important functions of Cyclin Y in 
vivo. These results led us to hypothesize that Cyclin Y is involved in molecular 
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pathways outside of, or in addition to phosphorylation and activation of Arrow in the 
canonical Wingless pathway in Drosophila (Liu et al., 2010).  
 Our results of the tissue wide CycY knockdown screen, shown in Chapter 2, 
support this hypothesis. RNAi-mediated targeting of Cyclin Y in the en-Gal4 or ser-Gal4 
expression patterns did not show wing notching, a phenotype that is expected for 
mutants in canonical Wingless pathway genes and specifically for arrow mutants 
(Sharma and Chopra, 1976; Wehrli et al., 2000; Willert et al., 1999). Also, a 
myristoylation defective G2A Cyclin Y-YFP that is not membrane localized and, 
therefore, would not be expected to efficiently activate Arrow (Davidson et al., 2009), 
can suppress the CycY shRNA wing blister phenotype (Chapter 3). This suggests that 
Cyclin Y has functions outside the canonical Wingless pathway since membrane 
localization is not required for the role that Cyclin Y plays in preventing wing blisters. To 
confirm that wing notching is the expected phenotype due to downregulation of the 
canonical Wingless pathway and not wing blisters, in this chapter, I knocked down 
arrow in the wing disc in the en-Gal4 or ser-Gal4 expression pattern.  
 Rather than a defect in wg signaling, the CycY shRNA-induced wing blister 
phenotype indicates a failure of cell adhesion between the two epithelial layers of the 
wing blade through their basal membrane. Normally, cells adhere to the extracellular 
matrix (ECM) through focal adhesion complexes that bridge the ECM to the cell 
cytoskeleton and defects in this process result in wing blisters (Brown, 1993; Brown, 
2000; Brown et al., 2000). Focal adhesion is governed by the integrin pathway and its 
cross talk with other pathways, including the Rho pathway (Huveneers and Danen, 
2009). Overexpression of Paxillin, a focal adhesion docking protein, causes a wing 
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blister that can be suppressed by overexpression of a downstream member of the Rho 
pathway, LIMK1 [69]. LIMK1 has two known roles in focal adhesion. One role is to 
promote Actin filament assembly by negatively regulating the disassembly factor Cofilin, 
while the other role is to activate the Serum Response Factor (SRF) transcription factor, 
which controls many genes required for focal adhesion (Chen et al., 2004; Ohashi et al., 
2000; Schratt et al., 2002). To link Cyclin Y to a molecular pathway in the wing disc, we 
hypothesized that Cyclin Y is required in the focal adhesion process through the Integrin 
pathway or Rho pathway. In this chapter I tested for a genetic interaction between 
Cyclin Y and LIMK1 and found that LIMK1 overexpression could suppress the wing 
blister phenotype induced by the CycY shRNA.  
  
 Another protein that has been shown to play a role in the Rho pathway is Cdk5. 
Cdk5 is also a potential partner for Cyclin Y in C. elegans (Ou et al., 2010). In the Rho 
pathway, Cdk5 is required for cell-matrix adhesion in rabbit lens epithelial cells 
N/N1003A (Negash et al., 2002). It is also required for the activation of the Rho-ROCK 
pathway in human lens epithelial cells (Tripathi and Zelenka, 2009) as well as for PAK1 
phosphorylation in COS cells (Rashid et al., 2001).  P35 is the known Cdk5 partner, yet 
to the best of our knowledge, while Cdk5 is ubiquitously expressed in Drosophila, p35 is 
either not expressed or expressed at low levels in the wing discs. (Chintapalli et al., 
2007; Graveley et al., 2011; Ou et al., 2010). Since p35 binds to Cdk5, overexpression 
of p35 in the wing disc could result in sequestration of the Cdk5 making it unavailable 
for a possible function with Cyclin Y in the Rho pathway. I tested for genetic interaction 
between CycY and p35  in the Drosophila wing discs and found that p35 overexpression 
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greatly enhanced the wing blister phenotype and significantly increased the number of 
flies with wing blisters induced by the CycY shRNA. This suggests that the Cyclin Y’s 
putative cell adhesion function in the wing disc could, be at least partly, through its 




4.2. MATERIALS AND METHODS 
4.2.1 Fly stocks 
 For arrow knockdown, I used a dsRNA that targets arrow that was created by 
the pTRiP project (Bloomington stock center # 31473, Finley stock # 983). For testing 
LIMK1 genetic interactions, UAS-LIMK1 (Bloomington stock center # 9116, Finley fly 
stock # 980) was crossed with the CycY shRNA to construct a fly strain UAS-LIMK1, 
UAS-CycY-shRNA (Finley stock # 1097). This fly strain was crossed with ser-Gal4 and 
the F1 wings were quantified. For testing the p35 genetic interaction, UAS-p35; TM3-
Ser/Sb (Finley fly stock # 447) was crossed with the CycY shRNA to construct a fly 
strain UAS-p35, UAS-CycY-shRNA (Finley stock # 1096). This fly strain was crossed 
with ser-Gal4 and the F1 wings were monitored and quantified. Both LIMK1 and p35 














4.3.1. Expression of an arrow-targeting dsRNA in the engrailed or serrate patterns 
does not phenocopy the CycY shRNA. 
 If Cyclin Y functions exclusively in the canonical Wingless pathway by 
recruiting Cdk14 to the cell membrane where it phosphorylates the Wg co-receptor 
Arrow, then we might expect similar phenotypic consequences from knocking down 
arrow or CycY. To test this I expressed a dsRNA targeting arrow in the en-Gal4 and ser-
Gal4 expression patterns and compared the resulting phenotypes to those induced by 
the CycY shRNA (see Chapter 2). Neither en-Gal4 driven nor ser-Gal4 driven 
expression of the arrow dsRNA showed any wing blistering or wing crumpling as seen 
in CycY knockdown (Fig. 4-1 a & b). Instead, targeting arrow in the en-Gal4 or ser-Gal4 
patterns resulted in notched wings in 34% (+/-4) and 5% (+/-0) of the animals 
respectively, a phenotype that is known for mutants of the canonical Wingless pathway 
genes and specifically for arrow mutants (Sharma and Chopra, 1976; Wehrli et al., 
2000; Willert et al., 1999). The strikingly different phenotypes between the arrow dsRNA 
and the CycY shRNA suggest that, in the wing discs, Cyclin Y has other functions 








Figure 4-1 Expression of a dsRNA against arrow in the wing discs results in wing 
notching and not wing blisters. Both engrailed or serrate driven expression of arrow 
dsRNA results in wing notching in 34% (+/-4) (n=24, 32, 41) and 5%(+/-0) (n=63, 38) 
respectively and no wing blisters in the Drosophila wing discs. Figures ai, aii, bi, and bii 
are from Figures 2-8 and 2-9. 
 
4.3.2. Overexpression of LIMK1, a cofilin kinase, results in supression of the CycY 
shRNA induced wing blister phenotype.  
 The wing blister and absence of margin defects that occured upon expression 
of the CycY shRNA in wing discs suggests that Cyclin Y functions in a pathway other 
than the canonical Wingless pathway. The wing blister phenotype indicates a failure of 
cell adhesion between the two epithelial layers of the wing blade through their basal 
membrane. To test for a functional relationship between Cyclin Y and the Rho pathway, 
I tested whether overexpression of LIMK1 could suppress the wing blister phenotype 
induced by the CycY shRNA in the wing discs in the ser-Gal4 pattern. As shown in 
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Figure 4-2, overexpression of LIMK1 completely supressed the CycY shRNA-induced 
wing blister. Whereas ser-Gal4-driven expression of the CycY shRNA resulted in distal 
wing blisters in 44% of the flies, none of the flies had wing blisters in the presence of a 
UAS-LIMK1 transgene  (one tail t-test- p=2.9E-05) (Figure 4-2). This suggests that 
Cyclin Y and LIMK1 have cooperative roles in the cell adhesion of the wing blades and 







Figure 4-2 LIMK1 functionally interacts with Cyclin Y in the Drosophila wing 
discs. Ser-Gal4 driven expression of the CycY shRNA resulted in distal wing blisters in 
44% (+/-3) of the flies. Overexpression of LIMK1 resulted in complete supression of the  
wing blisters (one tail t-test- p=2.9E-05). Ser-Gal4/+, UAS-CycY shRNA/+ and Ser-
Gal4/+, UAS-mCherry shRNA/+ are from Fig. 2-9. The x-axis shows the % of flies with 
wing blisters and the y-axis shows the different genotypes tested in this experiment. 
Error bars = S.E.M.  
 
 While the wing blister phenotype was completely supressed by the 
overexpression of LIMK1, interestingly, the combination of CycY shRNA and LIMK1 
overexpresssion resulted in the formation of ectopic wing veins with high penetrance 
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(95%; +/- 5; Figure 4-2 A). Extra wing veins were not seen with CycY knockdown or 
LIMK1 overexpresssion alone. This result suggests that  Cyclin Y and LIMK1 have 
antagonistic functions in wing vein formation in the wing intervein tissue.   
   
4.3.3. P35 overexpression in the wing discs results in the wing blister phenotype 
enhancement.  
Another protein that has been shown to play a role in the Rho pathway is Cdk5 (Negash 
et al., 2002; Rashid et al., 2001; Tripathi and Zelenka, 2009). Cdk5 is a potential cdk 
partner for Cyclin Y in C. elegans (Ou et al., 2010). Even though Cdk5 is ubiquitously 
expressed, P35 is either not expressed or expressed at low levels in the wing discs. 
(Chintapalli et al., 2007; Graveley et al., 2011; Ou et al., 2010). Studies in the C. 
elegans nervous system show that Cyclin Y and Cdk14 act in a parallell pathway with 
P35 and Cdk5 (Ou et al., 2010). Ou and colleagues (Ou et al., 2010) suggest that Cdk5 
could be another partner to Cyclin Y based on their finding that Cdk5 kinase activity 
increases in the presence of CYY-1 in an in vitro kinase assay. To test for genetic 
interactions between CycY and P35 in the wing discs, I crossed a UAS-P35 fly strain 
with the CycY shRNA fly strain to obtain a new fly strain: UAS-P35; UAS CycY shRNA. I 
used P35 overexpression (UAS-P35;TM3-Ser/Sb) & CycY knockdown (+/+,UAS-CycY 
shRNA) as controls for the experiment. I crossed each of those strains with ser-Gal4. As 
indcated in Figure 4-3, expression of P35 along with the CycY shRNA in the serrate 
expression pattern resulted in a severe enhancement of the wing blister phenotype. The 
CycY shRNA resulted in 44% (+/-3) of the flies with wing blisters in the distal side of the 
wing (Fig. 2-9) while P35 expression resulted in 26% (+/-8) of the flies with wing blisters 
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(Fig. 4-3). When p35 and the Cyclin Y shRNA were co-expressed, the wing blister 
phenotype was seen in 97% (+/-2) of the flies (t-test p=1.5E-07). In addition, the wing 
blister phenotype was more severe than the CycY shRNA alone (Fig. 4-3). These 
results suggest that Cyclin Y and Cdk5 have cooperative roles in the cell adhesion of 
the wing blades. Expression of p35 in the wing, where it is not normally expressed, may 








Figure 4-3: P35 functionally interacts with Cyclin Y in the Drosohila wing discs. 
Ser-Gal4-driven expression of the CycY shRNA resulted in distal wing blisters in 44% 
(+/-3) of the flies. Overexpression of p35 resulted in the phenotype enhancement where 
97% (+/-2) of the flies had wing blisters (one tail t-test- p=1.5E-07) that were more 
severe in appearance. Ser-Gal4/+, UAS-CycY shRNA/+ and Ser-Gal4/+, UAS-mCherry 
shRNA/+ are from Fig. 2-9. The x-axis shows the % of flies with wing blisters and the y-




4.4. DISCUSSION AND CONCLUSIONS  
 
Previous phenotypic analysis of CycY nulI flies and our tissue wide screen strongly 
suggest that Cyclin Y has functions outside the canonical wingless pathway. In this 
chapter I showed that the arrow dsRNA did not phenocopy the Cyclin Y loss of function 
phenotypes in the Drosophila wings. Instead, it resulted in wing notching, a phenotype 
that is expected for mutants in the canonical Wingless pathway genes and specifically 
for arrow mutants (Sharma and Chopra, 1976; Wehrli et al., 2000; Willert et al., 1999). 
This supports that Cyclin Y has functions outside of arrow activation in the canonical 
Wingless pathway. In support of this, a myristoylation defective G2A Cyclin Y-YFP that 
is not membrane localized and, therefore, would not be expected to efficiently activate 
Arrow (Davidson et al., 2009), suppressed the CycY shRNA wing blister phenotype 
(Chapter 3). Thus, membrane localization is not required for the role that Cyclin Y may 
play in preventing wing blisters.  
 The wing blister phenotype suggests that Cyclin Y may be involved in cell 
adhesion, which is governed by the integrin pathway and its cross talk with other 
pathways. The Rho pathway is a main participant in this process (Huveneers and 
Danen, 2009). Loss of function in members of the Rho pathway, such as the dSRF 
transcription factor, results in wing phenotypes including wing blisters and defects in 
wing vein and intervein patterns depending on the severity of the dSRF loss (Fristrom et 
al.; Montagne et al.).  Interestingly, even though I only saw extra wing veins with the 
CycY shRNA was when co-expressed with LIMK1, wing vein defects were seen in other 
CycY loss of function experiments (Liu, 2010) and (Figure 4-4). 69B-Gal4 driven CycY 
knockdown in the wing disc using a dsRNA resulted in extra wing vein formation (Liu, 
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2010). Consistently, the few CycY null escapers that flexed their wings showed clear 
disruption of the wing vein–intervein pattern in the wing blades (Figure 4-4). The 69B-
Gal4 expression of the CycY shRNA resulted in lethality by the larval stage, which 
precluded parallel comparisons between the CycY shRNA and dsRNA in the wings. The 
CycY dsRNA expressed with en-Gal4 or ser-Gal4 did not result in wing blisters. All the 
Cyclin Y loss of function wing phenotypes are also seen in defects in the Rho pathway 
(Fristrom et al.; Montagne et al.). The fact that all of those different wing phenotypes are 
not seen together in each Cyclin Y loss of function experiment done in this study and in 
previous ones (Liu, 2010) could be explained by the fact that those experiments target 
different spatial and temporal regions of the wing disc. It could also be due to different 
levels of severity of the Cyclin Y loss in the different experiments, or a combination of 
both reasons.  
 
Figure 4-4. Cyclin Y null escapers show wing crumpling, wing vein defects and no 
wing notching. 3 out of 6 CycYE8 null escapers show flexed wings (Genotype: E8/E8; 
+/+). All 3 of these flies have wing crumpling and unclear distinction between wing vein 
and intervein tissue (i and ii). The wing crumpling is Cyclin Y specific because it is 
rescued with a genomic Cyclin Y transgene where only 1 out of 69 flies show a wing 
blister (Genotype: E8/E8; gCycY/+) (iii). 
 
 
 Consistent with a possible role for Cyclin Y in the Rho pathway or in 
cooperation with the Rho pathway, I observed a strong genetic interaction between 
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Cyclin Y and LIMK1, a downstream member of the Rho pathway (Chen et al., 2004). 
Overexpression of LIMK1 suppressed the wing blister phenotype generated by the 
CycY shRNA, suggesting that Cyclin Y and LIMK1 function cooperatively in positively 
regulating cell adhesion between wing blades. Interestingly, the combination of CycY 
shRNA and LIMK1 overexpression also resulted in extra wing veins with full penetrance 
similar to the phenotype generated by 69B driven expression of a CycY dsRNA (Liu, 
2010). En-Gal4 driven LIMK1 overexpression was also shown in another study to result 
in extra wing vein formation (Chen et al., 2005). These results suggest that Cyclin Y and 
LIMK1 act antagonistically in wing vein formation in the wing intervein tissue, at least in 
the engrailed expression pattern, where Cyclin Y suppresses extra wing vein 
development and LIMK1 enhances it.  
 Intriguingly, studies in human cells and C. elegans also point to a possible role 
for Cyclin Y in the Rho pathway. A recent study in hepatocellular cancer cells (HKCI-3 
and HKCI-C3), found that forced expression of Cyclin Y and Cdk14 resulted in an 
increase of GTP-bound Rho pathway components, RhoA, Rac1 and Cdc42 and 
increased stress fiber formation, a process regulated by the Rho pathway (Sun et al., 
2014). In C. elegans, Cdk16, a known Cyclin Y Cdk partner was shown to genetically 
interact with and function epistatically to DHC-1 and NUD-2, two members of the Dynein 
complex. Also in C. elegans, Cdk5 was shown as a putative Cyclin Y partner. The Rho 
pathway has been connected to both the Dynein complex and Cdk5 functions in 
previous studies. In wounded NIH 3T3 fibroblasts, Cdc42, Dynein and Dynactin were 
required for mediating reorientation of the microtubule organizing center (MTOC), and 
Cdc42 functioned epistatically to Dynein and Dynactin in this process (Palazzo et al., 
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2001). Cdk5 was shown to be required for cell-matrix adhesion in rabbit lens epithelial 
cells (Negash et al., 2002), for activation of the Rho-ROCK pathway in human lens 
epithelial cells (Tripathi and Zelenka, 2009), and for PAK1 phosphorylation in COS cells. 
(Rashid et al., 2001). This is consistent with the results of a genetic interaction between 
Cyclin Y and p35 where forced expression of p35 in the wing discs combined with the 
knockdown of Cyclin Y, resulted in enhancement of the wing blister phenotype. This 
could be due to sequestration of Cdk5 by the ectopically expressed P35 rendering it 
unavailable for its function in cell adhesion. To the best of our knowledge, p35 is 
normally either not expressed or expressed at low levels in the wing discs. (Chintapalli 
et al., 2007; Graveley et al., 2011). The genetic interaction results between Cyclin Y and 
p35 also suggests that Cyclin Y and Cdk5 have a cooperative function in the cell 
adhesion process. 















CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
5.1. SUMMARY OF CONCLUSIONS: 
In this study I aimed to discover biological functions of Cyclin Y using Drosophila 
as a model organism. I started my study with a tissue-specific, tissue-wide knockdown 
screen for lethality in the different Drosophila developmental stages as well as abnormal 
phenotypes using a CycY shRNA and 31 Gal4 lines. The screen results suggested that 
Cyclin Y might be required in several biological systems for development and survival 
such as the nervous system and the gut. The screen results also supported our 
hypothesis that Cyclin Y has functions outside of the Drosophila canonical wingless 
pathway. Unlike arrow knockdown, there was no wing loss or wing notching upon 
knockdown of Cyclin Y in the wing discs. Instead, a wing blister phenotype was seen, 
which suggests a defect in cell adhesion between the wing blades. The wing blisters 
were partially rescued by a CycY shRNA resistant transgene, which supported that it is 
a Cyclin Y specific phenotype. Also in support to a function for Cyclin Y outside the 
canonical wingless pathway, expression of a myristoylation defective, non-
membranous, CycY shRNA resistant transgene partially rescued the wing blister 
phenotype. Finally, I showed that Cyclin Y genetically interacted with LIMK1 and p35; 




5.2. A Putative Model for the Cyclin Y Function in the Drosophila Wing Discs:   
 In this study, I showed that expression of a CycY shRNA, using en-Gal4 or ser-
Gal4, resulted in wing blister formation (Chapter 2). When LIMK1, a cofilin kinase and a 
member of the Rho pathway, was co-expressed with the CycY shRNA in the ser-Gal4 
expression pattern, the wing blister phenotype was supressed and extra wing veins 
developed (Chapter 4). One LIMK1 function is to phosphorylate and activate the 
transcrition factor dSRF (also known as Blistered) (Chen et al., 2004). Expression of a 
CycY dsRNA in the wing discs does not cause blisters but can result in extra wing vein 
formation in some tissue patterns (Liu, 2010), while CycY null escapers show a 
complete distortion in the wing vein, intervein pattern (Chapter 4). Blistered mutants 
show several phenotypes including wing blisters, extra wing vein formation and 
complete transformation of the wing to vein tissue (Fristrom et al.; Montagne et al.). 
These phenotypes are similar to the Cyclin Y mutant phenotypes and suggest, along 
with the genetic interaction between Cyclin Y and LIMK1, that Cyclin Y functions either 
in the Rho pathway or in a parallel pathway that has overlapping functions with the Rho 
pathway. Consistently, a recent study in hepatocellular cancer cells (HKCI-3 and HKCI-
C3) suggests a role for Cyclin Y in the Rho pathway where forced expression of Cyclin 
Y and Cdk14 resulted in an increased GTP-bound Rho pathway components, RhoA, 
Rac1 and Cdc42 and increased stress fiber formation, a process regulated by the Rho 
pathway (Sun et al., 2014).  
 Studies suggest that Cyclin Y physically and genetically interacts with Snr1, a 
members of the BRM complex (Giot et al., 2003; Liu, 2010; Terriente-Felix and de Celis, 
2009). Expression of an snr1 dsRNA in the Drosophila wing disc results in extra wing 
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vein formation in the wing intervein region (Liu, 2010). CycY dsRNA expression in wing 
disc also results in flies with the extra wing vein phenotype. The combined expression of 
both CycY dsRNA and snr1 dsRNA in the wing disc results in the enhancement of the 
extra wing vein phenotype (Liu, 2010). Snr1 activity is suggested to be regulated by 
Cyclin Y through phosphorylation (Liu, 2010). The extra wing vein phenotype is also 
observed in snr1 mutant flies, SNR1E1 (Marenda et al., 2004). This phenotype is 
enhanced by the loss of function blistered mutant, bs2 . The strong extra wing vein 
phenotype that is induced by the genetic interaction between the snr1 and the bs 
mutants is partially supressed by the Brm mutant brm2 (Marenda et al., 2004). Brm 
mutants show loss of wing veins (Liu, 2010; Marenda et al., 2004; Terriente-Felix and 
de Celis, 2009). Bs-LacZ expression is reduced in the wing interveins of the snr1 
mutant, snr1E1/snr1R3, pupal wings and is ectopically expressed in the L3 provein region 
when the brmK804R transgene is overexpressed (Marenda et al., 2004). These results 
suggest that Snr1 and Brm positively and negatively regulate blistered expression in the 
wing discs, respectively. (Marenda et al., 2004). They also provide some explanation to 
the extra wing vein phenotype observed with the Snr1 loss of function and the loss of 
wing veins observed with the Brm loss of function (Liu, 2010; Marenda et al., 2004). If 
Cyclin Y funtions in positive regulation of Snr1 in the wing discs, then loss of Cyclin Y 
function would result in downregulation of Snr1 and thus underexpression of Blistered. 
The similarity in the Cyclin Y and Blistered loss of function phenotypes such as the extra 
wing veins, the blistered wings and the disrupted wing vein structure strongly support 
this model (Chapter 2 & 4) and (Fristrom et al.; Liu, 2010; Montagne et al.) This is also 
supported by the suppression of the CycY shRNA wing blister phenotype upon 
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overexpression of LIMK1 (Chapter 4), an upstream regulator of blistered (Chen et al., 
2004) which also suggests that Cyclin Y and Snr1 are upstream of both LIMK1 and 
Blistered. When LIMK1 supressed the CycY shRNA wing blister, the extra wing vein 
phenotype was enhanced (Chapter 4). This could be explained by the fact that Snr1 
regulates several other contributors to the wing vein development other than Blistered 
such as delta, rhomboid and argos (Marenda et al., 2004; Terriente-Felix and de Celis, 
2009). It could also suggest that the wing blister phenotype is dominant to the extra 
wing vein phenotype.   
 Cyclin Y has two potential Cdk partners, Cdk14 and Cdk5. Both are expressed 
in Drosophila wings (Chintapalli et al., 2007; Graveley et al., 2011) and potentially have 
redundant functions (Liu and Finley Jr, 2010; Ou et al., 2010; Stanyon et al., 2004). Put 
together, I propose the following model (Figure 5-1). In the Drosophila wing discs, 
Cyclin Y along with Cdk14 or Cdk5 or both, binds to and activates Snr1 which in turn 
regulates many downstream targets. One result is positive regulation of Blistered 









Figure 5-1: A Putative Cyclin Y Functional Model in the Drosophila wing discs. 
Cyclin Y is upstream of members of the Rho pathway such as LIMK1 and SRF and 






5.3. FUTURE DIRECTIONS:  
 This study laid the foundation to many other possible future Cyclin Y functional 
studies. Several hypotheses about the functions of Cyclin Y in the wing discs as well as 
in other biological systems could be proposed and tested based on the results of this 
study and the proposed model.  
  Starting with the wing disc, I hypothesize that Cyclin Y mutants could affect 
SRF expression, regulation and hence its activity in regulating its target genes. This 
could be tested with measuring the expression level of dSRF in the wing discs upon 
alteration of the Cyclin Y expression level through knockdown or overexpression. Also 
SRF-responsive promoters such as SRE Luciferase could be used to measure the SRF 
transcrpition activity.  
 In addition to its function in dSRF activation, LIMK1 promotes actin filament 
assembly by negatively regulating the actin disassembly factor, cofilin  (Chen et al., 
2004; Ohashi et al., 2000; Schratt et al., 2002).  I hypothesize that Cyclin Y functions in 
F-actin stabilization and functions. Drosophila wing discs represent a good model 
system to study F-actin stabilization (Chen et al., 2005).  
 Countless other questions could be asked about the function of Cyclin Y in the 
wing discs. Here I propose a few more. In early stages of the Drosophila wing disc 
development, dSRF is expressed in the whole wing and then gradually lost from the 
vein tissue and restricted to the intervein tissue, where it functions cell autonomously 
(Fristrom et al.; Roch et al., 1998). What is the Cyclin Y expression pattern during 
different stages of the wing discs development and does it follow the dSRF expression 
pattern? Does Cyclin Y function cell autonomously?   
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 The Cyclin Y functional analysis could also be extended to other biological 
systems besides the wing discs in Drosophila. In the CycY knockdown screen described 
in chapter 2, I screened for lethality in each developmental stage in specific tissue 
patterns as well as for abnormal phenotypes in adult flies. 13 out of the 31 Gal4 lines 
showed lethality (Table 2-1). Each of the 14 tissue patterns could be used as a model to 
study other tissue specific Cyclin Y functions. But are all of the lethality results obtained 
from the screen due to specific CycY knockdown? To test that the lethality in each of 
the 13 Gal4 expression patterns is due to specific CycY knockdown, an shRNA resistant 
Cyclin Y could be expressed in each case. If the lethality is rescued by the shRNA 
resistant Cyclin Y, then we could conclude that Cyclin Y is specifically knocked down in 
those tissue patterns and that the lethality is Cyclin Y specific. The level of CycY could 
also be measured in each Gal4 tissue pattern upon knockdown with the CycY shRNA 
through in-situ hybridization and imaging of the dissected tissues of interest or through 
monitoring the fluorescent expression level of a fluorescently tagged Cyclin Y inserted in 
the tested flies.  
 Drosophila cultured cells could also be used to investigate hypotheses on 
some putative Cyclin Y functions. The Rho pathway controls the formation of cell 
protrusions such as fillopodia, lamellipodia and stress fibers (Nobes and Hall, 1999). 
Rho controls stress fiber and focal adhesion formation. Rac controls lamellipodia 
formation and Cdc42 controls fillopodia formation (Nobes and Hall, 1999). I hypothesize 
that Cyclin Y affects the formation or stability of cell protrusions. Cell protrusions could 




 And finally, the results in this study as well as previous Cyclin Y studies 
strongly suggest that Cyclin Y has functions outside the wingless pathway (Liu, 2010; 
Liu and Finley Jr, 2010). Another way to confirm that Cyclin Y functions outside the 
wingless pathway in the wing discs is by measuring the expression of a marker for the 
canonical Wingless pathway, e.g. senseless in the wing discs and compare it to 
canonical Wingless mutants such as arrow mutants as well as wild type larvae (Schertel 
et al.). Yet Cyclin Y could have functions in the canonical Wingless pathway in other 
Drosophila tissue patterns. A function for Cyclin Y in the canonical Wingless pathway 
could also be studied in the larval epidermis during the denticle belt formation process. 
Loss of function of the canonical Wingless pathway positive regulators results in an 
increase in the denticle area compared to wild type larvae (Swarup and Verheyen, 
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 1224 NG11 5'GGGGACAAGTTTGTACAAAAAAGCAGGCTCCGGCAA
AATGGGCAACAAG 
      
 1225 NG12 5’GGGGACCACTTTGTACAAGAAAGCTGGGTCCGATA
GTATGGCCACGCTG 
      
 1227 NG15 5’GCGATCATAACCCTAGTCTACC 
      
 1228 NG16 5’GGTAGACTAGGGTTATGATCGC 
      
 1231 NG21 5’GAGAACTCTGAATAGGCAATTGGGAAT 
      
 1232 NG22 5’CCTTCACAAAGATCCTCTAGCTTACGT 
      
 1233 NG23 5’AAGAAGAGAACTCTGAATAGGGAATTG 
      
 1234 NG24 5’CTGGTGAAATGCAGTTTAAGGTTTAC 
      
 1235 NG25 5’ATAACGGCTCTCTCTTTTATAGGTGTA 
      
      








Appendix C. Plasmids used or constructed in the study described in Chapter 
2. 
Plasmids 
Finely lab # 
Plasmids Alias Source or References 
2129 ptWV-attB This study 
2130 ptWH-attB This study 
1032 pUASt-attB (Bischof et al., 2007) 
989 pDonr221 (Invitrogen) 
966 pMT-Gal4 (Klueg et al., 2002) 
2121 CycY-pDonr221 This study 
2117 CycY no stop-pDonr221 This study 
2118 CycY-2pt-no stop-pDonr221 This study 
2127 pUASt-CycY-Venus-attB This study 
2123 pUASt-CycY-2pt-YFP-attB This study 
2125 pUASt-CycY-HA-attB This study 
2122 pUASt-CycY-2pt-HA-attB This study 









Appendix D: pUASt-GW-3xHA attB (pTWH-attB) anticipated sequence.  
pUASt-GW-3xHA-attB: 
UASt promoter: 4861 …  5225 
Gateway cassette: 5470 … 7173 
attR1: 5470 … 5487 
attR2: 7156 … 7173 

































































































































































































































Appendix E: pUASt-GW-Venus attB (pTWV-attB) anticipated sequence 
pUASt-GW-Venus-attB: 
UASt promoter: 4861 … 5225 
Gateway cassette: 5470 … 7173 
attR1: 5470 … 5487 
attR2: 7156 … 7173 




































































































































































































































































































































Appendix G. Wilcoxon Rank Sum p-values for the adult flies survival test in 
the CycY tissue wide knockdown screen. 
 Males Females 
Gal4 
line 
Exp. 1 Exp. 2 Exp. 3 Exp. 1 Exp. 2 Exp. 3 
No Gal4 0.327 NA 0.021 0.003 0.263 NA 
pnr  5.516E-
05 
NA 0.035 0.001 NA 1.783 E-
04 en  ND ND ND 0.056 0.004 3.655E-
06 Sca  NA NA 0.021 NA NA 2.682E-
06 C253  0.015 NA 0.182 0.089 NA NA 
MHC  0.564 0.300 0.317 NA NA NA 
Eip71CD  0.151 0.003 0.049 NA 7.792E-05 0.001 
Ser  ND ND ND 0.030 NA 1.293E-
06 cg  NA NA 0.048 0.014 NA 1.312E-
04 vg  0.334 2.199 E-
04 
0.005 0.051 NA 2.187E-
09 4G  0.074 NA 0.137 1.590E-04 NA 7.350E-
05 D42  0.002 NA NA 6.912E-05 1.606E-04 7.569E-
06 48Y  ND 2.182E-05 5.627E-
06 
ND 1.507E-06 1.436E-
06 OK376  NA NA NA NA NA NA 
Sgs3  NA 0.064 NA NA 0.450 NA 





1.743E-06 NA NA 
Mef2  NA 0.057 5.577E-
07 
1.015E-10 NA NA 
Feb36  0.317 NA 0.037 0.015 0.094 NA 
Aug21  0.031 0.304 NA 0.002 3.295E-05 1.488E-
04 Hml  0.503 NA 0.251 1.584E-08 0.055 3.368E-
04 c601  NA NA NA NA 4.782E-08 1.120E-
05 c578  NA NA NA 0.017 0.019 NA 
r4  0.106 NA 0.160 NA NA NA 
Wg NA 0.078 NA NA NA NA 
Repo 0.078 0.274 0.173 NA 0.037 0.095 
GMR 0.032 NA NA NA NA NA 
ELAV  0.003 0.233 0.001 2.607E-06 0.013 9.385E-















Alias  Genotypes Reference 

















923 Bl 31473 UAS-arr 
dsRNA 
y[1] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.JF01261}attP2 
 
(Ni et al., 
2008) 
923 Bl 35287 UAS-Cdk5 
shRNA 
y[1] sc[*] v[1]; P{y[+t7.7]  
v[+t1.8]=TRiP.GL00189}attP2 
(Ni et al., 
2011) 
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Cyclin Y is a highly conserved member of the Cyclin superfamily of proteins. 
In Drosophila the Cyclin Y gene (CycY) is required for progression through several 
stages of development but the specific pathways that Cyclin Y belongs to and that 
account for its requirement are not known. Studies in human and Drosophila cell 
lines have shown that membrane-localized Cyclin Y is required for phosphorylation 
of the wingless/Wnt co-receptor, arrow/LRP6, and for full activation of the canonical 
wingless/Wnt pathway. CycY null Drosophila, however, do not phenocopy loss-of-
function mutations in canonical wingless pathway genes, suggesting that Cyclin Y 
may have additional roles outside the wingless pathway in vivo. To identify roles for 
Cyclin Y in Drosophila I used RNAi to knock down CycY expression in 31 distinct 
tissue patterns. The screen revealed that expression of the CycY shRNA in specific 
tissue patterns causes larval lethality and other developmental defects. Knockdown 
of CycY but not arrow in imaginal discs resulted in bent legs and blistered wings, 
 121 
 
suggesting defects in the cell adhesion pathway. A transgene expressing a Cyclin Y 
variant that is not membrane localized suppresses some of the CycY knockdown 
phenotypes, further suggesting that they are not due to defective Arrow 
phosphorylation. Genetic and phenotypic evidence suggest that Cyclin Y interacts 
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